With the discipline of precision medicine as our foundation, Precision Medicine Group has brought together targeted expertise that can propel drug development and access. We apply relevant insights and specialized capabilities to unlock the potential of data—accelerating drug development, advancing manufacturing, and elevating engagement to deliver commercial success.

Precision is a global team of 3,500 experts operating across two groups: Precision for Medicine, the premier provider of biomarker-driven research and development, and Precision AQ, the foremost provider of commercialization services supporting life science organizations from launch through product maturity.